This document describes the state of knowledge of the adverse outcome pathway (AOP) for skin sensitisation initiated by covalent binding to proteins, assesses the weight-of-evidence supporting the AOP, identifies the key events, and identifies databases containing test results related to those key events. AOPs can be incorporated into chemical categories-based assessments or integrated approaches for testing and assessment.
The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins
Report
OECD Series on Testing and Assessment
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Report19 September 2024
-
Report19 September 2024
Related publications
-
Report19 September 2024
-
Report19 September 2024